Sutter Health among Premier's 15 Top Health Systems for 2025
Story Highlights Sutter Health ranked third among large health systems nationwide.
Premier's 15 Top Health Systems list evaluated 338 systems.
Top-ranked systems outperformed peers in mortality rates and efficiency.
Sutter Health was ranked among the best in the nation in Premier's 15 Top Health Systems in the United States.
The annual list ranks health systems based on clinical outcomes, extended outcomes, operational efficiency and patient experience. A total of 338 health systems were evaluated for the 2025 Premier's 15 Top Health Systems list.
GET TO KNOW YOUR CITY
Find Local Events Near You
Connect with a community of local professionals.
Explore All Events
To help spotlight the top hospitals and health systems across the nation, The Business Journals is partnering with Premier, a technology-driven, health care improvement company, to publish its annual rankings, including its 100 Top Hospitals ranking.
Sutter ranked No. 3 among five large health systems, following two based in Texas. It earned five stars, indicating performance in the top quintile, for clinical outcomes, which consider risk-adjusted mortality, complications, hospital-acquired infections, 30-day mortality and readmissions. It also received four stars for operational efficiency and patient experience.
Sutter is one of the largest employers, nonprofits and companies in the Sacramento region. It reported nearly $18 billion in revenue for fiscal 2024 and employs about 17,500 people in Sacramento, Placer, El Dorado and Yolo counties.
This year's top performers on Premier's 15 Top Health Systems rankings were Houston Methodist in Houston, Texas; Saint Francis Health System in Tulsa, Oklahoma; and CHI Memorial in Chattanooga, Tennessee, each of which topped its respective size category.
Only health systems with at least two short-term, general, acute care hospitals with separate Centers for Medicare & Medicaid Services Certification Numbers were included in the analysis.
Rankings were based on Medicare Provider Analysis and Review data, and data from the Centers for Medicare & Medicaid Services Care Compare website. Health systems do not apply to be considered.
The health systems on this year's rankings outperformed peer systems by 22% on inpatient mortality rates. They also had fewer infections and shorter stays compared to peers.
If the performance of this year's 15 Top Health Systems were extrapolated to all Medicare inpatients, more than 171,000 lives could be saved in-hospital and the typical patient could be released a half-day sooner.
Here are this year's 15 Top Health Systems:
Large Health Systems
1. Houston Methodist
City: Houston, TX
System type: Parent
2. Baylor Scott & White Health
City: Dallas, TX
System type: Parent
3. Sutter Health
City: Sacramento, CA
System type: System
4. Intermountain Health
City: Salt Lake City, UT
System type: Parent
5. UCHealth
City: Aurora, CO
System type: Parent
Medium Health Systems
1. Saint Francis Health System
City: Tulsa, OK
System type: Parent
2. HCA Continental Division
City: Denver, CO
System type: Subsystem
3. HCA Mountain Division
City: Cottonwood Heights, UT
System type: Subsystem
4. HCA Central and West Texas Division
City: Austin, TX
System type: Subsystem
5. CHI Health
City: Omaha, NE
System type: Subsystem
Small Health Systems
1. CHI Memorial
City: Chattanooga, TN
System type: Subsystem
2. CHRISTUS Spohn Health System
City: Corpus Christi, TX
System type: Subsystem
3. CHI Saint Joseph Health
City: Lexington, KY
System type: Subsystem
4. Health First
City: Rockledge, FL
System type: Parent
5. Baptist Health Care (Florida)
City: Pensacola, FL
System type: Parent
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
Missouri continues to lag behind most states in children's health, report finds
(Rebecca Rivas/Missouri Independent). Missouri ranked in the bottom third of all states for children's health, according to a report released Monday — due in part to a high rate of child and teen deaths. The annual Kids Count Data Book from the Annie E. Casey Foundation, which used data from 2023, evaluated all states on four metrics of child well-being: health, economic well-being, education, and family and community. Missouri ranked near the middle of states for overall child well-being, at 27th out of 50, weighed down by poor performance in health and education. Missouri's rankings in the four categories were: 13th in economic well-being, 33rd in education, 35th in health And 25th in family & community. 'Children's health remains an area of concern,' noted a press release Monday from Family and Community Trust, the Missouri-based nonprofit partner to Kids Count. Only nine states had higher rates of child and teen deaths in 2023 than Missouri, one of the factors considered in the health ranking. (Those were: Mississippi, Louisiana, New Mexico, Alabama, Tennessee, Arkansas, Alaska, Oklahoma and Montana.) Missouri generally ranks among the states with the highest rate of firearm deaths for kids. Firearms became the leading cause of kids' deaths in the United States in 2020, surpassing car accidents. While the national average in 2023 was 29 child and teen deaths per 100,000, that number was 37 deaths per 100,000 in Missouri. The national average rose overall in 2023. The report notes that while covid deaths contributed to the increase, the rise was largely due to rising firearm deaths and drug overdoses, particularly among teens ages 15 to 19. Also bringing Missouri's health ranking down: Missouri's rate of low-birth weight babies increased in 2023 from 2019 and is above the national average. Other factors helped Missouri's score. For one, Missouri has seen major improvements in children's insurance coverage since the state implemented Medicaid expansion in 2021. The rate of uninsured kids fell from 7% in 2019 to 5% in 2023, which is now on par with the national average. Nationally, Missouri saw among the sharpest declines in uninsured people overall from 2019 to 2023 with the expansion of Medicaid. Those gains could be threatened by Congress' budget proposal to reduce Medicaid spending in part by imposing more barriers to care. Teen births in the state have gone down, in line with national trends — though the state's average is still above the national one. The rate of overweight or obese kids has also improved in Missouri and is down to 31% of kids in 2023, on par with the national average. The rate of kids in poverty declined to 14% in the state in 2023, below the 16% national average. Missouri's education ranking slipped in recent years. In 2023, 77% of Missouri eighth graders were not proficient at math, according to the report, which is nearly 10 percentage points worse than 2019 and is worse than the national average. The press release from Family and Community Trust said the data show a 'continuing need to invest in education in Missouri.' SUPPORT: YOU MAKE OUR WORK POSSIBLE
Yahoo
4 hours ago
- Yahoo
Nevada health bill advances to Gov. Lombardo's desk
LAS VEGAS (KLAS) – Health bill SB 217 advanced in the Nevada legislature last week and is now on Governor Lombardo's desk awaiting his signature. The bill includes coverage for treatments like IVF, as well as fertility preservation for those who have been diagnosed with extreme illness. 'I had arthritis for most of my life. That drug that I was on, while helpful to my arthritis, was severely damaging to my egg reserves,' shared Stephanie Capellas-Glascock, who has been struggling with her infertility journey for years. 'I knew that it wasn't going to be something that I could accomplish on my own, so therefore I needed to look into fertility treatments for myself,' she explained. If signed, Nevada could become the first state in the nation to offer fertility coverage for Medicaid. However, the bill does face pushback for its cost and certain language in it. 'One of my concerns, just looking at it, so I may reserve my right to change my vote, is just the financial impact on our public employee benefit program that can go down to increasing premiums,' said Democratic Assembly Member Shea Backus, who did vote in favor. Meanwhile, the Nevada GOP party called on the governor to veto the bill. Their website cited their opposition because it 'declares embryos prior to implantation as non-human.' 'I don't think fertility treatments are a political issue. I think it's a health and medical issue,' Capellas-Glascock responded when asked about the opposition. 'We know that the GOP has some thoughts and feelings on that too, but I think the tremendous thing about IVF is that it is a miracle in medicine and science that really affords individuals the option to have a family, so when they're ready to start a family, they have that option.' When asked about the fiscal implications, she responded, 'There's always a cost associated. I think it's knowing that the pros supremely outweigh the cons.' The state estimated the cost would be about $38 million over the next two years. Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Medscape
6 hours ago
- Medscape
Part D Cancer Drug Launch Prices Soar Past Inflation
Launch prices for Medicare Part D anticancer drugs have risen sharply since 2012, with a mean increase of $1694 per year. In 2025, the observed prices were 15%-200% higher than expected if the increases were due to inflation alone, but the gap between observed and inflation-adjusted prices narrowed over the study period. METHODOLOGY: The Inflation Reduction Act of 2022 introduced price negotiation for Medicare-covered drugs and required manufacturers to pay rebates to Medicare for price increases above inflation. But it did not address the launch prices of new drugs. Anticancer drugs, a protected drug class with mandatory Medicare Part D coverage, may now be especially prone to higher launch prices, in part because the Inflation Reduction Act limits out-of-pocket spending and price increases after market entry. Researchers identified 86 branded, self-administered, molecularly targeted anticancer therapies approved by the FDA between January 2010 and December 2024. Data on drug prices were obtained from the Medicare Prescription Drug Plan Formulary and adjusted for inflation. The researchers looked at launch prices by year and compared drug prices in 2025 with those expected if launch prices had increased due to inflation alone since the drug's market entry. TAKEAWAY: The mean monthly launch price increased from $10,954 for drugs first observed in the Medicare formulary in 2012-2014 to $27,891 for drugs first observed in 2023-2025. After adjusting for inflation, the mean launch price increased by $1694 per year ( P < .001). < .001). In 2025, actual drug prices were 14.8%-200.9% higher than expected if they had only kept pace with inflation. Although the gap between observed and inflation-adjusted prices narrowed over time, price increases continued to outpace inflation in 2023 and 2024, despite the Inflation Reduction Act rebate requirement, which will result in rebates to Medicare starting in fall 2025. IN PRACTICE: 'Launch prices for self-administered targeted anticancer therapies have grown precipitously, although no evidence was found of disproportionate increases in recent years. Instead, continued launch price growth for anticancer therapies was observed, consistent with prior research,' the study authors wrote. 'This suggests that companies were already engaging in price maximization for anticancer therapies and continued to do so after the implementation of the [Inflation Reduction Act].' SOURCE: This study, led by Stacie B. Dusetzina, PhD, Vanderbilt University School of Medicine in Nashville, Tennessee, was published online in JAMA . LIMITATIONS: This study used example indications to determine monthly doses and pricing. Additionally, variations in available price measures were noted over the study period. DISCLOSURES: This study was funded by Arnold Ventures. Several authors reported receiving grants or personal fees and having other ties with various sources.
